The PE Ratio as of December 2024 (TTM) for Recursion Pharmaceuticals, Inc. (RXRX) is -4.70

According to Recursion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.70. This represents a change of -13.48% compared to the average of -5.43 of the last 4 quarters.

Recursion Pharmaceuticals, Inc. (RXRX) Historical PE Ratio (quarterly & annually)

How has RXRX PE Ratio performed in the past?

The mean historical PE Ratio of Recursion Pharmaceuticals, Inc. over the last ten years is -21.99. The current -4.70 PE Ratio has changed 2.04% with respect to the historical average. Over the past ten years (40 quarters), RXRX's PE Ratio was at its highest in in the September 2023 quarter at -4.41. The PE Ratio was at its lowest in in the March 2020 quarter at -41.11.

Recursion Pharmaceuticals, Inc. (RXRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Recursion Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Recursion Pharmaceuticals, Inc. (RXRX) Average PE Ratio

How has RXRX PE Ratio performed in the past?

The current PE Ratio of Recursion Pharmaceuticals, Inc. (RXRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Recursion Pharmaceuticals, Inc. (RXRX) PE Ratio vs. Peers

How is RXRX’s PE Ratio compared to its peers?

Recursion Pharmaceuticals, Inc.’s PE Ratio is less than Absci Corporation (-3.50), less than Affimed N.V. (-0.26), less than Sana Biotechnology, Inc. (-1.35), less than Relay Therapeutics, Inc. (-1.72), less than Immix Biopharma, Inc. (-2.93), less than CNS Pharmaceuticals, Inc. (-0.14), less than Hepion Pharmaceuticals, Inc. (-0.15), less than Freeline Therapeutics Holdings plc (-1.01), less than AVROBIO, Inc. (2.07), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Enveric Biosciences, Inc. (-0.27), less than CohBar, Inc. (-0.15), less than Ocean Biomedical, Inc. (-0.46), greater than Day One Biopharmaceuticals, Inc. (-14.52), less than Acumen Pharmaceuticals, Inc. (-1.32), greater than X4 Pharmaceuticals, Inc. (-6.95), less than Inozyme Pharma, Inc. (-1.92), greater than VectivBio Holding AG (-7.94),

Build a custom stock screener for Recursion Pharmaceuticals, Inc. (RXRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recursion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recursion Pharmaceuticals, Inc. (RXRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recursion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.